A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT05128825 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
310
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc